Annechien J A Lambeck - JoVE Visualize

Showing results (1-10 of 28) with videos related to

Pageof 3

Sort By:

HLA|July 23, 2024

HLA-B*51:197: A composite product of interlocus recombination of B*51:01:01:01 and C*01:02:01:01Niels Kouprie, Laura B Bungener, Annechien J A Lambeck, et al.

Laboratory Medicine|May 9, 2025

Detection of antinuclear antibodies: a survey done by the European Organsation for External Quality Assurance Providers in Laboratory MedicineDina Patel, Stéphanie Albarède, Werner Klotz, et al.

European Journal of Human Genetics : EJHG|February 19, 2015

CHARGE syndrome: a review of the immunological aspectsMonica T Y Wong, Elisabeth H Schölvinck, Annechien J A Lambeck, et al.

Vaccine|May 4, 2010

Role of T cell competition in the induction of cytotoxic T lymphocyte activity during viral vector-based immunization regimensAnnechien J A Lambeck, Hans W Nijman, Baukje Nynke Hoogeboom, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2010

Human plasmacytoid dendritic cells phagocytose, process, and present exogenous particulate antigenJurjen Tel, Annechien J A Lambeck, Luis J Cruz, et al.

Journal of Pediatric Gastroenterology and Nutrition|October 11, 2024

Lateral flow test versus enzyme-linked immunosorbent assay to measure infliximab trough concentrations: A head-to-head comparisonMarleen Bouhuys, Margreet M S Wessels, Willemien de Vries, et al.

Gynecologic Oncology|June 24, 2008

Survival of ovarian cancer patients overexpressing the tumour antigen p53 is diminished in case of MHC class I down-regulationNinke Leffers, Annechien J A Lambeck, Pauline de Graeff, et al.

The Journal of Allergy and Clinical Immunology. in Practice|October 28, 2018

Azathioprine Hypersensitivity Syndrome in a Cohort of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis PatientsArno C Hessels, Jan Stephan F Sanders, Annick A J M van de Ven, et al.

Blood|October 5, 2011

Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticityPaul J Tacken, Ingrid S Zeelenberg, Luis J Cruz, et al.

Clinical Immunology (Orlando, Fla.)|September 2, 2015

CD21 and CD19 deficiency: Two defects in the same complex leading to different disease modalitiesMarjolein W J Wentink, Annechien J A Lambeck, Menno C van Zelm, et al.

Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:

Pageof 3

HLA|July 23, 2024

HLA-B*51:197: A composite product of interlocus recombination of B*51:01:01:01 and C*01:02:01:01Niels Kouprie, Laura B Bungener, Annechien J A Lambeck, et al.

Laboratory Medicine|May 9, 2025

Detection of antinuclear antibodies: a survey done by the European Organsation for External Quality Assurance Providers in Laboratory MedicineDina Patel, Stéphanie Albarède, Werner Klotz, et al.

European Journal of Human Genetics : EJHG|February 19, 2015

CHARGE syndrome: a review of the immunological aspectsMonica T Y Wong, Elisabeth H Schölvinck, Annechien J A Lambeck, et al.

Vaccine|May 4, 2010

Role of T cell competition in the induction of cytotoxic T lymphocyte activity during viral vector-based immunization regimensAnnechien J A Lambeck, Hans W Nijman, Baukje Nynke Hoogeboom, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2010

Human plasmacytoid dendritic cells phagocytose, process, and present exogenous particulate antigenJurjen Tel, Annechien J A Lambeck, Luis J Cruz, et al.

Journal of Pediatric Gastroenterology and Nutrition|October 11, 2024

Lateral flow test versus enzyme-linked immunosorbent assay to measure infliximab trough concentrations: A head-to-head comparisonMarleen Bouhuys, Margreet M S Wessels, Willemien de Vries, et al.

Gynecologic Oncology|June 24, 2008

Survival of ovarian cancer patients overexpressing the tumour antigen p53 is diminished in case of MHC class I down-regulationNinke Leffers, Annechien J A Lambeck, Pauline de Graeff, et al.

The Journal of Allergy and Clinical Immunology. in Practice|October 28, 2018

Azathioprine Hypersensitivity Syndrome in a Cohort of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis PatientsArno C Hessels, Jan Stephan F Sanders, Annick A J M van de Ven, et al.

Blood|October 5, 2011

Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticityPaul J Tacken, Ingrid S Zeelenberg, Luis J Cruz, et al.

Clinical Immunology (Orlando, Fla.)|September 2, 2015

CD21 and CD19 deficiency: Two defects in the same complex leading to different disease modalitiesMarjolein W J Wentink, Annechien J A Lambeck, Menno C van Zelm, et al.

Pageof 3